Cancer Treatment Reviews
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 10.6 | Q1 | 90.1% | 3.745 | Q1 | 98.4% |
| 2024 | 10.5 | Q1 | 91.7% | 4.183 | Q1 | 98.8% |
| 2023 | 9.6 | Q1 | 88.9% | 3.667 | Q1 | 98.5% |
| 2022 | 11.8 | Q1 | 92.2% | 3.589 | Q1 | 98.5% |
| 2021 | 13.6 | Q1 | 93.3% | 3.214 | Q1 | 98.3% |
| 2020 | — | — | 4.278 | Q1 | 98.8% | |
| 2019 | — | — | 3.619 | Q1 | 98.4% | |
| 2018 | — | — | 3.537 | Q1 | 98.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1532-1967
ISSN
0305-7372
country
GBcoverage
1974-1991, 1993-2026